Rasha Fadly Mady

Rasha Fadly Mady

Auto-generated profile, based on publicly available information

Rasha Fadly Mady

Medical Parasitology Department, Faculty of Medicine, University of Alexandria, Alexandria, Egypt

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 August 2014 in Experimental Parasitology
Verified
Journal Article
Closed access
MGM.R. Gaafar
M.R. Gaafar
RMR.F. Mady
R.F. Mady
RDR.G. Diab
R.G. Diab
TSTh.I. Shalaby
Th.I. Shalaby

1 July 2012 in Experimental Parasitology
Verified
Journal Article
Closed access
MEMaha M. Eissa
Maha M. Eissa
MEMervat Z. El-Azzouni
Mervat Z. El-Azzouni
RMRasha F. Mady
Rasha F. Mady
FFFouad M. Fathy
Fouad M. Fathy
NBNahed M. Baddour
Nahed M. Baddour

7 October 2015 in Parasitology Research
Verified
Journal Article
Closed access
PDF file
RMRasha F. Mady
Rasha F. Mady
WEWessam El-Hadidy
Wessam El-Hadidy
SESamar Elachy
Samar Elachy

1 December 2017 in Parasitology International
Verified
Journal Article
Closed access
IAIman Fathy Abou-El-Naga
Iman Fathy Abou-El-Naga
EKEman Dorry El Kerdany
Eman Dorry El Kerdany
RMRasha Fadly Mady
Rasha Fadly Mady
TSThanaa Ibrahim Shalaby
Thanaa Ibrahim Shalaby
EZEnas Mohammed Zaytoun
Enas Mohammed Zaytoun

1 May 2020 in Biomédica
Verified
Journal Article
Open access
PDF file
IAIman Fathy Abou-El-Naga
Iman Fathy Abou-El-Naga
RMRasha Fadly Mady
Rasha Fadly Mady
NMNermine Mogahed Fawzy Hussien Mogahed
Nermine Mogahed Fawzy Hussien Mogahed
Introduction: Leishmaniasis remains one of the neglected tropical diseases. Repurposing existing drugs has proven to be successful for treating neglected tropical diseases while combination therapy is a strategic alternative for the treatment of infectious diseases.Auranofin, lopinavir/ritonavir, and sorafenib are FDA approved drugs used in the treatment of diverse diseases by acting on different essential biological enzymes.Objective: To evaluate the effects of monotherapy and combined therapies with the three drugs against Leishmania infantum.Materials and methods: We compared the leishmanicidal effects of the three drugs on promastigotes in vitro as regards the parasite count, the drug concentration providing a half-maximal response, and the ultrastructural changes of the parasite. We determined the fractional inhibitory concentration index of combined drugs in two ways, as well as the activity of the three drugs together to establish their synergetic effect.Results: The monotherapy with the three drugs was effective with auranofin showing the best leishmanicidal effect (EC50=1.5 μM), whereas sorafinib reduced parasite growth at EC50=2.5 μM. The scanning electron microscopy of promastigotes from all treated media showed distortion in the shape with loss of flagella and bleb formation. Acidocalcinosis was evident by transmission electron microscopy with all treatments suggesting apoptosis. Treatment with lopinavir/ritonavir showed signs of autophagy. The two-way combination of the drugs led to additive interactions while the combination of the three drugs showed synergistic action.Conclusion: Each drug when used as monotherapy against Leishmania spp. was effective, but the combination therapy was more effective than the individual drugs due to the additive or synergistic effects.

1 May 2015 in Parasitology Research
Verified
Journal Article
Closed access
PDF file
HSH. A. Sadaka
H. A. Sadaka
MGM. R. Gaafar
M. R. Gaafar
RMR. F. Mady
R. F. Mady
NHN. N. Hezema
N. N. Hezema